Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that its subsidiary, Broken Coast Cannabis, has received a license amendment from Health Canada that provides Broken Coast with an additional 18,000 square feet of production space as part of its Phase III expansion, bringing total production space to 44,000 square feet. As a result of the amendment, Broken Coast's production capacity will nearly double to 4,500 kg annually.
"We're pleased to receive Health Canada approval on our Phase III expansion, which will enable us to quickly ramp up production of our small-batch, premium, high-quality B.C. bud," said John Moeller, Co-founder and President of Broken Coast. "We expect the first crop cultivated and produced at the expansion to be available for sale by the end of July."
Broken Coast operates a fully-licensed, purpose-built, indoor cannabis production facility on Vancouver Island. The Health Canada license amendment falls under the Access to Cannabis for Medical Purposes Regulations (Canada) ("ACMPR").
"This is an important milestone for Broken Coast and for Aphria as we continue to bring online more capacity to meet the anticipated demand in the Canadian market," said Vic Neufeld, CEO of Aphria. "Broken Coast is one of Canada'smost sought after premium cannabis brands and is an important part of Aphria's portfolio of brands today and in the coming adult-use market later this year."
We Have a Good Thing Growing.
About Aphria
Aphria Inc., one of Canada's lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada. Aphria is truly powered by sunlight, allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
For more information, visit: www.aphria.ca.
SOURCE
Read More
Broken Coast Cannabis Nearly Doubles Production Capacity with Health Canada Approval of Phase III Expansion
